Fundraising Fox
Reid Huber
InvestorPartner at Third Rock Ventures
East Coast
Writes $100K – $5M checks · typically $1.5M
Find your path to Reid
Sign up to see every warm intro you have to Reid
- Paths you didn't know you had: your email and LinkedIn already hold routes to Reid. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Reid Huber is a Partner at Third Rock Ventures, which he joined in 2018, where he works on the formation, development and strategy of the firm's portfolio companies. He brings more than 25 years of operating experience in biotechnology, including as a member of the founding scientific team at Incyte in 2002, where he later served as Executive Vice President and Chief Scientific Officer. Earlier in his career he held roles of increasing responsibility at Dupont Pharmaceuticals and Bristol-Myers Squibb, and he completed postdoctoral training at the National Institutes of Health. His investing interests center on companies combining disease genetics, data science and translational medicine to create new medicines.
Contact· published on Reid's own website
Beyond investing
- Founded
- Was a member of the founding scientific team at Incyte in 2002.
- Education
- Earned a B.S. in Molecular Genetics and Biochemistry from Murray State University. Holds a Ph.D. in Human Molecular Genetics from Washington University School of Medicine in St. Louis.
Mentioned above: the Washington University School of Medicine in St. Louis mafia →
From Reid's own website — common ground for a warm intro.
Investments
Board seats
Sources: SEC Form D filings · curated public sources.
Colleagues at Third Rock Ventures
Frequently asked questions
- Who is Reid Huber?
- Reid Huber is a Partner at Third Rock Ventures, which he joined in 2018, where he works on the formation, development and strategy of the firm's portfolio companies. He brings more than 25 years of operating experience in biotechnology, including as a member of the founding scientific team at Incyte in 2002, where he later served as Executive Vice President and Chief Scientific Officer. Earlier in his career he held roles of increasing responsibility at Dupont Pharmaceuticals and Bristol-Myers Squibb, and he completed postdoctoral training at the National Institutes of Health. His investing interests center on companies combining disease genetics, data science and translational medicine to create new medicines.
- Where does Reid Huber work?
- Reid Huber is Partner at Third Rock Ventures.
- What check size does Reid Huber write?
- Reid Huber typically writes checks of $100K – $5M.
- What boards does Reid Huber sit on?
- Reid Huber holds tracked board seats at Synnovation Therapeutics.
- What companies has Reid Huber invested in?
- Investments tracked here include Asher Bio, CARGO Therapeutics, Merida Biosciences, Rapport Therapeutics, Synnovation Therapeutics, Syremis Therapeutics, Terremotobio.
Founder mafias
Third Rock Ventures mafia33
Also came through, then founded or led a company.
Washington University School of Medicine in St. Louis mafia14
Also came through, then founded or led a company.
Murray State University mafia5
Also came through, then founded or led a company.
Insitro mafia3
Also came through, then founded or led a company.
Tango Therapeutics mafia3
Also came through, then founded or led a company.
About this profile. Compiled from public sources — Third Rock Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights